Back to search
FDAFDA · Food and drugs·Recall number D-0899-2017

NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distributed by: Medtech Products, Inc., Tarrytown, NY 10591, UPC 8 148332 01101 7.

Published June 21, 2017 · Recall initiated: June 6, 2017

Summary

FDA records drug Class II recall D-0899-2017, published June 21, 2017 and initiated June 6, 2017. Recalling firm: Bausch & Lomb, Inc.; Status: Terminated; Reported quantity: 44,520 bottles; Lot: Lot: 253211, Exp 12/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bausch & Lomb, Inc.
Distributor
Nationwide in the USA
Lot
Lot: 253211, Exp 12/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distributed by: Medtech Products, Inc., Tarrytown, NY 10591, UPC 8 148332 01101 7. recalled?

Yes. FDA published recall D-0899-2017 on June 21, 2017. Reported hazard: CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

What should I do if I have this product?

Voluntary: Firm initiated · Letter